# C_2016445EN.01000801.xml

| 30.11.2016 | EN | Official Journal of the European Union | C 445/8 |
| --- | --- | --- | --- |

30.11.2016

EN

Official Journal of the European Union

C 445/8

---

Prior notification of a concentration

(Case M.8087 — Smiths Group/Morpho Detection)

(Text with EEA relevance)

(2016/C 445/05)

| 1. | On 23 November 2016, the Commission received notification of a proposed concentration pursuant to Article 4 and following a referral pursuant to Article 4(5) of Council Regulation (EC) No 139/2004 (1) by which the undertaking Smiths Group plc (‘Smiths’, United Kingdom) acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Morpho Detection, LLC and Morpho Detection International, LLC (together ‘Morpho Detection’, United States) by way of purchase of shares and assets. |
| --- | --- |

1.

On 23 November 2016, the Commission received notification of a proposed concentration pursuant to Article 4 and following a referral pursuant to Article 4(5) of Council Regulation (EC) No 139/2004 (1) by which the undertaking Smiths Group plc (‘Smiths’, United Kingdom) acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Morpho Detection, LLC and Morpho Detection International, LLC (together ‘Morpho Detection’, United States) by way of purchase of shares and assets.

1

| 2. | The business activities of the undertakings concerned are:
  —   for Smiths: global technology company with five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. Smiths Detection offers security solutions for customers worldwide. It develops and manufactures equipment that detects and identifies explosives, weapons, chemical agents, biohazards, nuclear and radioactive material, narcotics and contraband. It also offers services to maintain and upgrade its installed base of equipment and related products,
  —   for Morpho Detection: development and manufacturing of equipment for detecting and identifying explosive, radiological and nuclear threats, as well as narcotics and contraband. It also offers services to maintain and upgrade its installed base of equipment and related products. |
| --- | --- |

2.

The business activities of the undertakings concerned are:

—   for Smiths: global technology company with five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. Smiths Detection offers security solutions for customers worldwide. It develops and manufactures equipment that detects and identifies explosives, weapons, chemical agents, biohazards, nuclear and radioactive material, narcotics and contraband. It also offers services to maintain and upgrade its installed base of equipment and related products,

for Smiths

—   for Morpho Detection: development and manufacturing of equipment for detecting and identifying explosive, radiological and nuclear threats, as well as narcotics and contraband. It also offers services to maintain and upgrade its installed base of equipment and related products.

for Morpho Detection

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference M.8087 — Smiths Group/Morpho Detection, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference M.8087 — Smiths Group/Morpho Detection, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

---